It tells tissues to rebuild collagen, accelerate healing, and activate hair follicle growth cycles
In the Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes published in 2024, it was recommended to start GLP-1 RA sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients with T2DM and ASCVD, while also commenting upon noted benefit in specifically HFpEF as well [53]
Covers exenatide, semaglutide, tirzepatide, oral Wegovy, retatrutide, CagriSema, and the evolution from diabetes to obesity treatment
It is instrumental in producing nitric oxide (NO)a molecule that widens blood vessels and thus promotes blood flow through them
GLP-1 medications create a window an opportunity where dietary change feels more achievable because the biological noise of constant hunger is finally quieter